These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 434647)
41. Flagella on Legionnaires' disease bacteria: an interim report. Thomason BM; Chandler FW; Hollis DG Ann Intern Med; 1979 Aug; 91(2):224-6. PubMed ID: 380435 [No Abstract] [Full Text] [Related]
42. Culture procedures in the avirulent conversion of legionella pneumophila. Fumarola D J Infect Dis; 1980 Jan; 141(1):124. PubMed ID: 7365272 [No Abstract] [Full Text] [Related]
43. A quantitative microbial risk assessment model for Legionnaires' disease: animal model selection and dose-response modeling. Armstrong TW; Haas CN Risk Anal; 2007 Dec; 27(6):1581-96. PubMed ID: 18093054 [TBL] [Abstract][Full Text] [Related]
44. In vitro susceptibility of Legionella pneumophila, serogroups I-IV. Saravolatz LD; Pohlod DJ; Quinn EL J Infect Dis; 1979 Aug; 140(2):251. PubMed ID: 479642 [No Abstract] [Full Text] [Related]
45. Legionella, WIGA, et cetera: pathogens? Isenberg HD Ann Intern Med; 1979 Nov; 91(5):785-6. PubMed ID: 496120 [No Abstract] [Full Text] [Related]
46. Legionnaires' disease in Johannesburg. Kaplan C; Zwi S; Kallenbach J; Singer J; Koornhof HJ; Mauff AC; Dubery B S Afr Med J; 1980 Jul; 58(1):13-7. PubMed ID: 6996143 [TBL] [Abstract][Full Text] [Related]
47. Survival of the Legionnaires' disease bacterium in water. Skaliy P; McEachern HV Ann Intern Med; 1979 Apr; 90(4):662-3. PubMed ID: 434653 [TBL] [Abstract][Full Text] [Related]
48. Immunologic factors affecting the in-vivo and in-vitro survival of the Legionnaires' disease bacterium. Arko RJ; Wong KH; Feeley JC Ann Intern Med; 1979 Apr; 90(4):680-3. PubMed ID: 373551 [TBL] [Abstract][Full Text] [Related]
49. Legionnaires' disease: structural characteristics of the organism. Katz SM; Nash P Science; 1978 Feb; 199(4331):896-7. PubMed ID: 622573 [TBL] [Abstract][Full Text] [Related]
50. Laboratory diagnosis of Legionnaires' disease. Edelstein PH; Meyer RD; Finegold SM Am Rev Respir Dis; 1980 Feb; 121(2):317-27. PubMed ID: 6987923 [TBL] [Abstract][Full Text] [Related]
51. Legionnaires' Disease associated with potting soil--California, Oregon, and Washington, May-June 2000. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2000 Sep; 49(34):777-8. PubMed ID: 10987244 [TBL] [Abstract][Full Text] [Related]
52. Recent advances in the structure, biochemical and biological aspects of the "Legionella pneumophila", the causative agent of Legionnaires' disease: a review. Fumarola D Ann Sclavo; 1979; 21(1):63-9. PubMed ID: 384938 [No Abstract] [Full Text] [Related]
53. Four serogroups of Legionnaires' disease bacteria defined by direct immunofluorescence. McKinney RM; Thacker L; Harris PP; Lewallen KR; Hebert GA; Edelstein PH; Thomason BM Ann Intern Med; 1979 Apr; 90(4):621-4. PubMed ID: 86313 [TBL] [Abstract][Full Text] [Related]
54. Macroscopic pathology of the lungs in Legionnaires' disease. Winn WC; Glavin FL; Perl DP; Craighead JE Ann Intern Med; 1979 Apr; 90(4):548-51. PubMed ID: 434632 [TBL] [Abstract][Full Text] [Related]
55. Pathogenetic mechanisms in legionnaires' disease. Fumarola D Br Med J; 1979 Sep; 2(6193):796. PubMed ID: 519205 [No Abstract] [Full Text] [Related]
56. Legionnaires' disease caused by Legionella pneumophila serogroup 3. Taylor AG; Harrison TG Lancet; 1979 Jul; 2(8132):47. PubMed ID: 87929 [No Abstract] [Full Text] [Related]